Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: implantable cardioverter + magnets + 712  Related to the article below (Last Update: 8/4/2008)

Strategic Programming of Detection and Therapy Parameters in ...
Cardiosource, DC -
Study Question: How effectively does strategic programming of implantable cardioverter defibrillators (ICDs) reduce shocks in high-risk patients without ...
Extended charge banking model of dual path shocks for implantable ...
7thSpace Interactive (press release), NY - Aug 1, 2008
Single path defibrillation shock methods have been improved through the use of the Charge Banking Model of defibrillation, which predicts the response of ...

RTT News
St. Jude Medical earnings rise; ICD sales rebound
Forbes, NY - Jul 16, 2008
"They are taking share not just in ICDs (implantable cardioverter defibrillators), but also in pacemakers," said BMO Capital Markets analyst Joanne Wuensch. ...
St. Jude Medical earnings up, shares rally guardian.co.uk
UPDATE 4-St. Jude Medical earnings up, shares rally Reuters India
St. Jude Medical's product sales appear recession-proof Minneapolis Star Tribune
Forbes - Forbes
all 67 news articles »  STJ - BSX - MDT
Routine shock-energy testing in primary-prevention ICDs questioned ...
TheHeart.Org, NY -
... threshold (DFT) testing in most patients receiving implantable cardioverter defibrillators (ICDs) for primary prevention of sudden death [1]. ...
Before the Bell-St. Jude shrs jump after earnings beat estimates
Reuters UK, UK - Jul 16, 2008
The cardiovascular device maker said second-quarter earnings rose 55 percent as sales of its implantable cardioverter defibrillators rebounded from a year ...
Good start to quarter fans optimism about medtech Reuters
all 11 news articles »  STJ
Heart Healthy: Preventive Medicine 2008
Medscape (subscription) -
Dr. Lindsey then discussed primary and secondary SCD prevention using implantable cardioverter defibrillators (ICDs), patient selection for device ...
Halifax Health
OR-Live, CT - Jul 9, 2008
An implantable cardioverter-defibrillator (ICD) is a battery-powered device that significantly improves the chances of survival in people at high risk for ...
St. Jude Is a Fighter
Motley Fool - Jul 18, 2008
Past stumbles by competitors Medtronic (NYSE: MDT) and Boston Scientific (NYSE: BSX), which have both had to issue recalls of their implantable cardioverter ...STJ
Heart Experts Seek Better Monitoring of Patients With Implantable ...
Journal of American Medical Association (subscription), IL - Jul 22, 2008
... implantable cardioverter-defibrillators (ICDs), cardiac resynchronization devices, implantable loop recorders, and implantable cardiovascular monitors ...
HomeCARE II: BIOTRONIK Launches Clinical Study Using Innovative ...
MarketWatch - Jul 31, 2008
... is included on the BIOTRONIK Lumax 540 series implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) ...
Source: Google News

Cardiac rehabilitation in patients with implantable defibrillators -
W Kamke, C Dovifat, M Schranz, S Behrens, J … - Zeitschrift f?r Kardiologie, 2003 - Springer
... although during our study magnet ap- plication ... Am J Cardiol 87:712?715 14. ... atrial
tachyarrhythmias in patients with implantable cardioverter defibrilla- tors ...

User navigation and guidance during configuration and storage of parameters for medical device -
TN Anderson, JD Higinbotham, DA Miller, M Schwartz … - US Patent 6,842,644, 2005 - freepatentsonline.com
... defibrillators, automatic implantable cardioverter defibrillators, pacing ... for a custom
implantable medical device ... 719 of buttons includes magnet/beeper button ...

Secure telemetry system and method for an implantable cardiac stimulation device -
JD Snell, LS Sloman - US Patent 6,600,952, 2003 - freepatentsonline.com
... and/or tachycardia, an implantable cardioverter-defibrillator (ICD ... is placed over
the pacemaker, which magnet may be ... device with which the implantable device is ...

-
RM Powell - US Patent 5,549,654, 1996 - Google Patents
... closed) by placing a magnet over the ... Uplink telemetry capabilities in an implantable
device system ... In known pacemaker/cardioverter/defibrillators (PCDs), both ...

Self adjusting optimal waveforms
S Hofstadter, MW Kroll - US Patent 7,283,871, 2007 - freepatentsonline.com
... IEGM storage also can be achieved by magnet. ... intended to operate as an implantable
cardioverter/defibrillator (ICD ... in a determination block 712 that determines ...

… experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy -
C Deaton, SB Dunbar, M Moloney, SF Sears, MR … - Heart & Lung-The Journal of Acute and Critical Care, 2003 - Elsevier
... Implantable cardioverter defibrillator (ICD) with atrial therapies (ICD-AT) therapy
is market ... at a particular time of their choosing with a pacemaker magnet. ...

… pacing and prolonging atrial refractoriness using an implantable cardiac stimulation device -
E Park, GA Bornzin, JJ Florio, JW Poore, LS Sloman … - US Patent 6,606,517, 2003 - freepatentsonline.com
... also performs as a cardioverter/defibrillator, the battery ... The implantable cardiac
stimulation device 10 further includes a magnet detection circuitry ...

-
M Paris - US Patent 7,031,766, 2006 - Google Patents
... POST EXERCISE NO 712 NO 700 ... The term "implantable cardioverter defibrillator" or
simply "ICD" is used herein to refer to any implantable cardiac 20 device. ...
-

-
BM Mann, M Endaya, PA Levine - US Patent 6,311,089, 2001 - Google Patents
... (12) United States Patent Mann et al. (54) IMPLANTABLE STIMULATION DEVICE AND METHOD
FOR DETERMINING VENTRICULAR AND ATRIAL SENSITIVITY THRESHOLDS ...

Implantable stimulation device and method for determining atrial autocapture using programmable … -
BM Mann, M Endaya, PA Levine - US Patent 6,243,606, 2001 - freepatentsonline.com
... 21 shows a simplified functional block diagram of an implantable cardioverter-
defibrillator (ICD), which represents one type of implantable stimulation device ...

Source: Google Scholar
 
 

Magnets May Pose Serious Risks For Patients With Pacemakers And ICDs
Article Date: 04 Dec 2006 - 5:00am (PST)

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of Heart Rhythm.

Researchers found that while common magnets for home and office use, with low magnetic strength posed little risk, stronger magnets made from neodymium-iron-boron (NdFeB) may cause interference with cardiac devices and pose potential hazards to patients. NdFeB magnets are increasingly being used in homes and office products, toys, jewelry and even clothing.

"Physicians should caution patients about the risks associated with these magnets," says Thomas Wolber, a cardiologist at the University Hospital of Zurich in Switzerland and lead author of the study. "We also recommend that the packaging include information on the potential risks that may be associated with these types of magnets."

Two spherical magnets of eight and 10 millimeters in diameter and one necklace made of 45 spherical magnets were tested on 70 patients, 41 with pacemakers and 29 with ICDs. Magnetic interference was observed in all patients. The cardiac devices resumed normal function after the magnets were removed.

In an accompanying editorial, Huagui Li, M.D., a cardiologist at the Minnesota Heart Clinic in Edina, MN., writes, "This study is timely and important to attract the attention of both the public and the medical profession about the potentially serious health consequences of magnets used in decoration products - for an ICD patient, the magnet interference can be fatal."

Dr. Li concludes that manufacturers who use magnets should be required to put warning labels on their products for optimal patient safety.

Article continues below and (thank you)

 

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of over 4,000 heart rhythm professionals in more than 60 countries around the world.

About Heart Rhythm

Heart Rhythm provides rapid publication of the most important science developments in the field of arrhythmias and cardiovascular electrophysiology. As the Official Journal of the Heart Rhythm Society, Heart Rhythm publishes both basic and clinical subject matter of scientific excellence devoted to the electrophysiology (EP) of the heart and blood vessels, as well as therapy. The journal is the only EP publication serving the entire electrophysiology community from basic to clinical academic researchers, private practitioners, technicians, industry and trainees. Heart Rhythm received a debut Impact Factor of 2.6 and was ranked 21st out of 72 cardiovascular medicine journals by the Institute for Scientific Information. Additionally, the journal ranks fifth in the Immediacy Index among cardiology publications. It is also the official publication of the Cardiac Electrophysiology Society.

Contact: Rachael Lille Moore
GYMR

 

Clues To How Diet Affects The Immune System: Do Healthy Bodies Help Fight Disease?

"This study may help explain the link between dietary fat consumption and inflammation and could be one of the critical links between metabolism and immune responses," says senior author Professor Charles Mackay, Director of Sydney's Garvan Institute's Immunology Program.

Our intake of fats (fatty acids) has changed dramatically over the last thirty years. At the same time there has been an increase in inflammatory diseases in the western world - especially asthma, atherosclerosis, and autoimmune diseases such as rheumatoid arthritis. "We have shown that a subset of white blood cells, called dendritic cells, which initiate immune responses, rely on the fatty acid binding molecule aP2 for their function. It is possible that different fatty acids or their total levels will affect aP2 function in dendritic cells, and hence affect immune responses," explains Mackay.

Professor Mackay added: "What we want to do now is study whether it is the total levels of fats or the different types of fats that alter dendritic cell function, through their binding to aP2. We know that dietary changes can improve symptoms of rheumatoid arthritis and we believe that a 'diet hypothesis' may account for the dramatic changes in inflammatory diseases seen in the western world over the past 30 years -molecules such as aP2 may be one of the clues that will help explain this phenomenon."

Over-activation of dendritic cells can trigger inflammatory diseases. This discovery reveals aP2 is key to that process. Fatty acid binding molecules, such as aP2, have already been identified as promising targets for the treatment of metabolic disorders such as type 2 diabetes and atherosclerosis. This new research suggests that medicines directed at aP2 would have great potential in inflammatory as well as metabolic diseases.

###

This research is published in the December 1 edition of the well-reputed Journal of Immunology. This work was supported in part by grants from the Cooperative Research Centre for Asthma, National Health and Medical Research Council, the National Institutes of Health, and the Sandler Program. Numerous studies have shown that fats such as omega 3, best known for being found in fish, linseed, and sunflower oil, improve clinical outcomes for rheumatoid arthritis.

ABOUT GARVAN

The Garvan Institute of Medical Research was founded in 1963 by the Sisters of Charity. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with approximately 400 scientists, students and support staff. The Garvan Institute's main research programs are: Cancer, Diabetes & Obesity, Arthritis & Immunology, Osteoporosis, and Neuroscience. It is part of the St Vincent's Hospital Campus.

Contact: Dr Branwen Morgan
Research Australia
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 

 © 2002-2006

Keywords::

Contact Iconocast

Home Page